StonvexLoading…
StonvexStonvexStonvexCore line items from IDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.75B | $1.77B | $1.64B | $1.56B |
Operating Income | $353.98M | $327.84M | $313.48M | $327.18M |
Net Income | $323.47M | $289.17M | $261.19M | $258.98M |
EPS (Diluted) | $5.90 | $5.50 | $5.14 | $5.11 |
Total Assets | $10.23B | $9.24B | $8.48B | $7.54B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $215.72M | $368.87M | $327.43M | $177.58M |
Free Cash Flow OCF − CapEx | $-577.49M | $-414.86M | $-344.11M | $-81.30M |
Shares Outstanding | 54.81M | 52.62M | 50.81M | 50.70M |